Is a kidney cancer medicine used for treating rare tumour U.S.A.'s sanctioning

Is a kidney cancer medicine used for treating rare tumour U.S.A.'s sanctioning
Washington, November 1 ( Reporter Ren HaiJun) American Food and Drug Administration announce, approve the intersection of Swiss and the intersection of Novartis and the intersection of kidney and the intersection of cancer and the intersection of medicine and Iraq of Company for link and does not manage using for treating a kind of rare tumour 1 - -Star-shaped cell tumour of big and small afterbirth under the ependyma.
The star-shaped cell tumour of big and small afterbirth is a kind of rare central nervous system tumour under the ependyma, mostly a kind of manifestation in the central nervous system of nodular sclerosis. American medicine is in charge of office's introducing, some patients who suffered from such rare tumour can only treat through surgery in the past, have no relevant medicine to use. Now, Iraq links and does not manage being used in those patients who can't carry on surgery treatment.
In link in the new the intersection of use and clinical trial that carry on of Si Mo to Iraq, big and small the intersection of afterbirth and star-shaped patient, tumour of cell, accept 6 months such as treatment such as medicine under the 28 ependyma, tumour in that in 9 patient's body has narrowed over half; 4 patients once excised tumour before the clinical trial but subsequently through the operation tumour recured, accept after Iraq links and does not manage the treatment, the tumours of 3 patients have dwindled by more than 50%; All patients participating in clinical trial have not produced new tumour in the body, but tumour without a patient totally disappears.
In charge of the introduction to the office according to American medicine, the main side effect that this medicine appears in the clinical trial includes upper airway infection, nasal sinus and ear infecting with, oral cavity pain and have a fever.
|